Rachel Cant

592 total citations
6 papers, 479 citations indexed

About

Rachel Cant is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, Rachel Cant has authored 6 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Rheumatology and 2 papers in Dermatology. Recurrent topics in Rachel Cant's work include Systemic Sclerosis and Related Diseases (5 papers), Dermatological and Skeletal Disorders (2 papers) and Dupuytren's Contracture and Treatments (2 papers). Rachel Cant is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Dermatological and Skeletal Disorders (2 papers) and Dupuytren's Contracture and Treatments (2 papers). Rachel Cant collaborates with scholars based in United Kingdom. Rachel Cant's co-authors include Marzena Ciechomska, Steven O’Reilly, Jacob M. van Laar, Angus Dalgleish, Rachel Allen, James Finnigan, Thomas Hügle, Fiona Oakley and Sophie Hambleton and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Cytokine & Growth Factor Reviews.

In The Last Decade

Rachel Cant

6 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Cant United Kingdom	6	199	159	140	103	72	6	479
Akiko Tochimoto Japan	14	187 0.9×	175 1.1×	118 0.8×	86 0.8×	58 0.8×	26	517
Oliver Wengert Germany	8	148 0.7×	142 0.9×	148 1.1×	58 0.6×	23 0.3×	10	501
Emi Nishimagi Japan	8	218 1.1×	120 0.8×	88 0.6×	48 0.5×	81 1.1×	13	360
M Fukayama Japan	10	83 0.4×	75 0.5×	132 0.9×	51 0.5×	35 0.5×	23	347
Shun Kitaba Japan	15	239 1.2×	210 1.3×	107 0.8×	94 0.9×	305 4.2×	27	723
Manuela Kolster Germany	6	194 1.0×	383 2.4×	80 0.6×	39 0.4×	21 0.3×	9	555
Małgorzata Kowal Poland	18	170 0.9×	368 2.3×	187 1.3×	32 0.3×	123 1.7×	53	769
Lisa Kaly Israel	10	82 0.4×	82 0.5×	116 0.8×	77 0.7×	24 0.3×	46	402
Marie‐Pierre Moles France	6	255 1.3×	382 2.4×	144 1.0×	45 0.4×	72 1.0×	13	710
Sara S. McCoy United States	13	105 0.5×	81 0.5×	69 0.5×	63 0.6×	45 0.6×	38	519

Countries citing papers authored by Rachel Cant

Since Specialization

Citations

This map shows the geographic impact of Rachel Cant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Cant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Cant more than expected).

Fields of papers citing papers by Rachel Cant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Cant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Cant. The network helps show where Rachel Cant may publish in the future.

Co-authorship network of co-authors of Rachel Cant

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Cant. A scholar is included among the top collaborators of Rachel Cant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Cant. Rachel Cant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Cant, Rachel, Angus Dalgleish, & Rachel Allen. (2017). Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors. Frontiers in Immunology. 8. 809–809. 46 indexed citations

2.

O’Reilly, Steven, Marzena Ciechomska, Rachel Cant, & Jacob M. van Laar. (2014). Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein. Journal of Biological Chemistry. 289(14). 9952–9960. 197 indexed citations

3.

O’Reilly, Steven, Rachel Cant, Marzena Ciechomska, et al.. (2014). Serum amyloid A induces interleukin‐6 in dermal fibroblasts via Toll‐like receptor 2, interleukin‐1 receptor‐associated kinase 4 and nuclear factor‐κB. Immunology. 143(3). 331–340. 62 indexed citations

4.

Ciechomska, Marzena, Rachel Cant, James Finnigan, Jacob M. van Laar, & Steven O’Reilly. (2013). Role of toll-like receptors in systemic sclerosis. Expert Reviews in Molecular Medicine. 15. e9–e9. 33 indexed citations

5.

O’Reilly, Steven, Rachel Cant, Marzena Ciechomska, & Jacob M. van Laar. (2013). Interleukin‐6: a new therapeutic target in systemic sclerosis?. Clinical & Translational Immunology. 2(4). e4–e4. 72 indexed citations

6.

O’Reilly, Steven, Marzena Ciechomska, Rachel Cant, Thomas Hügle, & Jacob M. van Laar. (2012). Interleukin-6, its role in fibrosing conditions. Cytokine & Growth Factor Reviews. 23(3). 99–107. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact